Home > Insider Trading > Filing (0001209191-18-049795)

Filing Details

Accession Number:: 0001209191-18-049795
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-09-06 16:18:55
Reporting Period:: 2018-09-04

Accepted Time:: 2018-09-06 16:18:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1294133	Inogen Inc	INGN	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1596103	Brenton Taylor	C/O Inogen, Inc. 326 Bollay Drive Goleta CA 93117	Evp, Engineering	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-09-04	5,000	$16.62	41,297	No	4	A	Direct
Common Stock	Disposition	2018-09-04	2,700	$258.24	38,597	No	4	S	Direct
Common Stock	Disposition	2018-09-04	800	$259.09	37,797	No	4	S	Direct
Common Stock	Disposition	2018-09-04	600	$260.47	37,197	No	4	S	Direct
Common Stock	Disposition	2018-09-04	500	$261.90	36,697	No	4	S	Direct
Common Stock	Disposition	2018-09-04	100	$262.45	36,597	No	4	S	Direct
Common Stock	Disposition	2018-09-04	300	$263.68	36,297	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-09-04	5,000	$0.00	5,000	$16.62

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,311		2021-03-31	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	842	Indirect	By Spouse

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.
Represents the weighted average share price of an aggregate total of 2,700 shares sold in the price range of $257.71 to $258.60 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 800shares sold in the price range of $258.80 to $259.46 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 600shares sold in the price range of $260.00 to $260.74 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 500shares sold in the price range of $261.30 to $262.21 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014
Reporting person's Form 4 filed on 04/02/2014 incorrectly reported the Expiration Date as 04/01/2024.